PDCD1 and melanoma: In line with these metabolic changes, PD-1-deficient Tbet+NK1.1− ILCs expressed significantly increased IFNγ and granzyme B and K. Furthermore, PD-1-deficient Tbet+NK1.1− ILCs contributed toward diminished tumor growth in an experimental murine model of melanoma.